Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936660 · ClinicalTrials.gov registry record · NA
A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
A NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 1,049
- Enrollment target
- 20
- Study locations
NCT03936660 is a NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases that has completed, run by Duke University. The registered enrollment target is 1,049 participants, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (77% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT03936660, a NA study of Diabetes Mellitus, Type 2 and Cardiovascular Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,049 participants
- Enrollment target
- 20
- Study locations
Study Summary
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.
Conditions Studied
Interventions
- OTHER Intense Education Intervention
Study Locations (20)
Florida
- Orlando Heart and Vascular Institute - Altamonte Springs
- Riverside Medical Center/Synergy Healthcare - Bradenton
- Lennar Foundation/Univ. of Miami - Coral Gables
- Citrus Cardiology - Inverness
- Baptist Health Research Institute - Jacksonville
- Advanced Research for Health Improvement, LLC - Naples
- Cardiovascular Inst. of Northwest Florida - Panama City
- Bayfront Cardiovascular Associates - St. Petersburg
- Interventional Cardiac Consultants - Trinity
Alabama
- Grandview Health/Alabama Cardiovascular Group - Birmingham
- USA Cardiology - Mobile
California
- Stanford University - Stanford
- Blue Coast Cardiology - Vista
Illinois
- Advocate Heart Institute - Chicago
- Advanced Heart Care Group/Medicoricium LLC - Fairview Heights
Alaska
- Alaska Heart and Vascular Institute - Anchorage
Arizona
- Dignity Health/DHMG Specialty Medicine - Phoenix
Colorado
- Aurora Denver Cardiology - Denver
Connecticut
- Bridgeport Hospital - Bridgeport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,049 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03936660
The ClinicalTrials.gov registry entry for NCT03936660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,049 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (77% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Intense Education Intervention is the first listed.
NCT03936660 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT03936660 about?
NCT03936660 is a clinical study titled "A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease". COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.
What is the current status of trial NCT03936660?
This trial is currently completed. It is a NA study. The enrollment target is 1,049 participants. The study started on 2019-07-25. Estimated completion is 2022-12-30.
What conditions does trial NCT03936660 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases.
What interventions are being tested in trial NCT03936660?
The interventions under investigation include: Intense Education Intervention (OTHER).
Who is sponsoring clinical trial NCT03936660?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03936660 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.